๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Modified angiogenesis inhibitor for selective targeting of tumours

โœ Scribed by Khabir Ahmad

Book ID
117783174
Publisher
The Lancet
Year
2004
Tongue
English
Weight
163 KB
Volume
5
Category
Article
ISSN
1470-2045

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

The selective P-TEFb inhibitor CAN508 ta
The selective P-TEFb inhibitor CAN508 targets angiogenesis
โœ Vladimรญr Kryลกtof; Lucie Rรกrovรก; Johanna Liebl; Stefan Zahler; Radek Jorda; Jiล™รญ ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› Elsevier Science ๐ŸŒ French โš– 683 KB
VEGF-mediated tumour angiogenesis: a new
VEGF-mediated tumour angiogenesis: a new target for cancer therapy
โœ Georg Martiny-Baron; Dieter Marmรฉ ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 510 KB

Considerable evidence is gathering for the involvement of vascular endothelial growth factor (VEGF) in the vascularization and growth of primary tumours as well as in the formation of metastases. The expression of VEGF depends on activated oncogenes and inactivated tumour suppressor genes as well as